IMMUNOREACTIVE endothelin (ETi) and atrial natriuretic peptide (ANPi) blood levels were measured by radioimmunoassay in patients with clinically defined sepsis. The interaction between these two peptides and their relation to circulatory shock and mortality were studied.
Introduction
Sepsis is a life threatening syndrome, mostly induced by bacterial infections, which may be complicated by shock, multiple organ failure, and which carries a high mortality. The severity of the disease is generally believed to be aggravated by the release and activation of endogenous mediators in response to bacterial products, like endotoxins. An imbalance between vasodilating and vasoconstrictive factors may result in systemic vasodilatation, and selective vasoconstriction in circumscript vascular beds, as in the kidney.
Since it has become evident that endothelium cells are capable of releasing vasoactive substances that regulate vascular smooth muscle tone, these substances have raised growing interest with regard to the pathogenesis of the cardiovascular changes induced by septic shock. '2 It is well documented that endothelin (ET), a peptide produced and secreted by the endothelium, has extremely potent vasoconstrictor and vasopressor actions and decreases cardiac output and renal blood flow. 3'4 Recent studies showed a five-to ten-fold increase of ET in the sepsis syndrome. 5'6 Atrial natriuretic peptide (ANP), which is released by the cardiac atria in response to a rise in blood pressure and volume, induces a fall in blood pressure and a rise in renal (C) (Table 2 ). The ETi levels followed the severity of illness and were higher in patients who died than in survivors" 28.6 + 13.3 vs. (Table 3) .
ETi levels in patients with septic shock appeared to be significantly (p < 0.01) higher than in normotensive septic patients, again in contrast to ANPi levels. Furthermore, we also found a negative correlation between ETi and mean arterial pressure (r -0.47, p < 0.05).
In eleven patients we tested serial samples during a period of six consecutive days after admission. The evolution of ETi plasma levels over time is shown in Fig. 1 
